Sfoglia per AUTORE
TESSA M
Collezione ASL Asti

  

Items : 7

Beyond D'Amico risk classes for predicting recurrence after external beam radiotherapy for prostate cancer: the Candiolo classifier. in Radiation oncology (London, England) / Radiat Oncol. 2016 Feb 24;11:23. doi: 10.1186/s13014-016-0599-5.

2016
ASL Torino 4
ASL Biella
ASL Asti
ASL Vercelli

Tessa M; Moro G; Girelli G; Krengli M; Gabriele D; Gabriele P; Garibaldi E; Jereczek-Fossa BA;

Survey on gynecological cancer treatment by Piedmont, Liguria, and Valle d'Aosta group of AIRO (Italian Association of Radiation Oncology). in Journal of contemporary brachytherapy / J Contemp Brachytherapy. 2016 Apr;8(2):128-34. doi: 10.5114/jcb.2016.59286. Epub 2016 Apr 14.

2016
ASL Asti
ASL Vercelli

Urgesi A; Krengli M; Scolaro T; Chiarlone R; Tessa M; Giannelli F; Melano A; Gribaudo S; Bresciani S; Delmastro E; Cattari G; Gabriele P;

Predicting recurrence after 3DC Radiotherapy for prostate cancer: Proposal for a new classifier in Radiotherapy and Oncology

2016
ASL Biella
ASL Torino 4
ASL Asti
ASL VCO

Jereczek-Fossa B; Krengli M; Garibaldi E; Tessa M; Moro G; Girelli G; Bona C; Balcet V; Ferrazza P; Gabriele D;

HDR brt in endometrial cancer: Experience of two fractionation schedules and results of 14 years with 57 patients in Radiotherapy and Oncology

2012
ASL Asti

Gribaudo S; Tessa M; Madon E; Richetto V; Masenga D; Monetti U; Mussano A; Urgesi A; Nassisi D; Cosma S;

Variation in gynecological oncology follow-up practice: Attributable to cancer centers or to patient characteristics? A Piedmont Regional Oncology Network Study in Tumori

2011
ASL Asti
ASL Torino 4

Fuso L; Evangelista A; Pagano E; Piovano E; Perotto S; Mazzola S; Bertoldo E; La Porta MR; Rosmino C; Furbatto G; Abate S; Di Costanzo G; Trossarelli G; Carnino F; Gambaro G; Piantanida P; Alabiso O; Galletto L; Zavallone L; Rossi A; Barbero M; Tessa M; Katsaros D; Danese S; Brignolo P; Gorzegno G; Grillo R; Apolone G; Ciccone G; et alii...

Radiotherapy alone or with concomitant daily low-dose carboplatin in locally advanced, unresectable head and neck cancer: definitive results of a phase III study with a follow-up period of up to ten years. in Tumori / Tumori. 2010 Mar-Apr;96(2):246-53.

2010
ASL Torino 4
ASL Asti
AOU San Luigi di Orbassano

Ruo Redda MG; Ragona R; Ricardi U; Beltramo G; Rampino M; Gabriele P; Allis S; La Porta MR; Moro G; Melano A; Gabriele AM; Tessa M; Fossati P; Orecchia R;

Concomitant chemotherapy and external radiotherapy plus brachytherapy for locally advanced esophageal cancer results of a retrospective multicenter study in Tumori

2005
ASL Asti
ASL Torino 4

Tessa M; Rotta P; Ragona R; Sola B; Grassini M; Nassisi D; Sciacero P; Airoldi M; Filippi A; Gianello L; De Angelis C; Ozzello F; Trotti AB; Ricardi U; Sannazzari GL;